UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Maternity services in the UK during the coronavirus disease 2019 pandemic: a national survey of modifications to standard care

BJOG : an international journal of obstetrics and gynaecology, 2021-04, Vol.128 (5), p.880-889

2021

Volltextzugriff (PDF)

Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction

BJOG : an international journal of obstetrics and gynaecology, 2011-04, Vol.118 (5), p.624-628

2011

Volltextzugriff (PDF)

Refreshing our magnesium sulphate strategy

BJOG : an international journal of obstetrics and gynaecology, 2022-02, Vol.129 (3), p.392-392

Magee, LA

2022

Volltextzugriff (PDF)

Performance of the fullPIERS model in predicting adverse maternal outcomes in pre‐eclampsia using patient data from the PIERS (Pre‐eclampsia Integrated Estimate of RiSk) cohort, collected on admission

BJOG : an international journal of obstetrics and gynaecology, 2013-01, Vol.120 (1), p.113-118

2013

Volltextzugriff (PDF)

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

The Lancet (British edition), 2000-01, Vol.355 (9198), p.87-92

2000

Volltextzugriff (PDF)

Toll‐like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre‐eclampsia

BJOG : an international journal of obstetrics and gynaecology, 2010-01, Vol.117 (1), p.99-108

2010

Volltextzugriff (PDF)

Aspirin and pre‐eclampsia: the heart of the matter?

BJOG : an international journal of obstetrics and gynaecology, 2020-07, Vol.127 (8), p.1026-1026

2020

Volltextzugriff (PDF)

Use of proton pump inhibitors during pregnancy and rates of major malformations: A meta-analysis

Digestive diseases and sciences, 2002-07, Vol.47 (7), p.1526-1529

2002

Volltextzugriff (PDF)

Dalteparin for the prevention of recurrence of placental‐mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.58-64

2009

Volltextzugriff (PDF)

Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review

BJOG : an international journal of obstetrics and gynaecology, 2014-09, Vol.121 (10), p.1210-1218

2014

Volltextzugriff (PDF)

Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction

Placenta (Eastbourne), 2006, Vol.27 (1), p.56-61

2006

Volltextzugriff (PDF)

Research priority setting in women’s health: a systematic review

BJOG : an international journal of obstetrics and gynaecology, 2020-05, Vol.127 (6), p.694-700

2020

Volltextzugriff (PDF)

The impact of pre‐eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy – analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study)

BJOG : an international journal of obstetrics and gynaecology, 2021-07, Vol.128 (8), p.1373-1382

2021

Volltextzugriff (PDF)

Can risk prediction models help us individualise stillbirth prevention? A systematic review and critical appraisal of published risk models

BJOG : an international journal of obstetrics and gynaecology, 2021-01, Vol.128 (2), p.214-224

2021

Volltextzugriff (PDF)

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial

BJOG : an international journal of obstetrics and gynaecology, 2016-06, Vol.123 (7), p.1143-1151

2016

Volltextzugriff (PDF)

Subclassification of Preeclampsia

Hypertension in pregnancy, 2003, Vol.22 (2), p.143-148

2003

Volltextzugriff (PDF)

PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a systematic review and meta-analysis

Pregnancy hypertension, 2023-09, Vol.33, p.e38-e38

2023

Volltextzugriff (PDF)

PO6_03. Do lower blood pressure cut-offs in obese pregnant women identify women at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of upbeat data

Pregnancy hypertension, 2023-09, Vol.33, p.e31-e31

2023

Volltextzugriff (PDF)

Optimal timing of delivery in pregnancies with pre‐existing hypertension

BJOG : an international journal of obstetrics and gynaecology, 2011-01, Vol.118 (1), p.49-54

2011

Volltextzugriff (PDF)

PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia

Pregnancy hypertension, 2023-09, Vol.33, p.e38-e39

2023

Volltextzugriff (PDF)

PO6_18. The additive role of the SFLT-1/PLGF ratio among women with preeclampsia for prediction of preeclampsia with severe features within two weeks

Pregnancy hypertension, 2023-09, Vol.33, p.e37-e37

2023

Volltextzugriff (PDF)

PO6_16 Reduced maternal plasma and urine calcium concentrations in women with pre-eclampsia

Pregnancy hypertension, 2023-09, Vol.33, p.e36-e36

2023

Volltextzugriff (PDF)

Prepregnancy body mass index and adverse perinatal outcomes in the presence of other maternal risk factors

AJOG global reports, 2023-05, Vol.3 (2), p.100175-100175, Article 100175

2023

Volltextzugriff (PDF)

Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?

BJOG : an international journal of obstetrics and gynaecology, 2016-06, Vol.123 (7), p.1135-1141

2016

Volltextzugriff (PDF)

Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?

Acta obstetricia et gynecologica Scandinavica, 2002-07, Vol.81 (7), p.642-648

2002

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(146)

Publikationsform

Artikel
(169)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(78)
Humans
(69)
Female
(53)
Pregnancy
(48)
Biological And Medical Sciences
(38)
Obstetrics & Gynecology
(38)
Medical Sciences
(32)
Adult
(28)
Hypertension
(18)
Physical Sciences
(17)
Animals
(16)
Gynecology. Andrology. Obstetrics
(15)
Pharmacology. Drug Treatments
(13)
Infant, Newborn
(12)
Male
(12)
Pregnancy. Fetus. Placenta
(12)
Risk Factors
(12)
Diabetes Mellitus
(11)
Diseases Of Mother, Fetus And Pregnancy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maternity services in the UK during the coronavirus disease 2019 pandemic: a national survey of modifications to standard care

Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction

Refreshing our magnesium sulphate strategy

Performance of the fullPIERS model in predicting adverse maternal outcomes in pre‐eclampsia using patient data from the PIERS (Pre‐eclampsia Integrated Estimate of RiSk) cohort, collected on admission

Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

Toll‐like receptors 2 and 4 and the cryopyrin inflammasome in normal pregnancy and pre‐eclampsia

Aspirin and pre‐eclampsia: the heart of the matter?

Use of proton pump inhibitors during pregnancy and rates of major malformations: A meta-analysis

Dalteparin for the prevention of recurrence of placental‐mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review

Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction

Research priority setting in women’s health: a systematic review

The impact of pre‐eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy – analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study)

Can risk prediction models help us individualise stillbirth prevention? A systematic review and critical appraisal of published risk models

Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial

Subclassification of Preeclampsia

PO6_19. The diagnostic accuracy of American college of cardiology/American heart association blood pressure categories for identification of women and babies at risk of adverse pregnancy outcomes – a systematic review and meta-analysis

PO6_03. Do lower blood pressure cut-offs in obese pregnant women identify women at greater risk of adverse maternal and perinatal outcomes? A secondary analysis of upbeat data

Optimal timing of delivery in pregnancies with pre‐existing hypertension

PO6_21. The utility of the SFLT-1/PLGF ratio among patients with or without hypertension who are suspected of having preeclampsia

PO6_18. The additive role of the SFLT-1/PLGF ratio among women with preeclampsia for prediction of preeclampsia with severe features within two weeks

PO6_16 Reduced maternal plasma and urine calcium concentrations in women with pre-eclampsia

Prepregnancy body mass index and adverse perinatal outcomes in the presence of other maternal risk factors

Control of Hypertension In Pregnancy Study randomised controlled trial—are the results dependent on the choice of labetalol or methyldopa?

Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?

Suchergebnisse filtern